About Guocai!

Some people describe the price of water in high-value medical consumables as a towel in a basin, "you just pour it on when you pick it up, you don't need to squeeze it at all

After that, the original circulation mode was completely changed, and the links of production, sales, distribution, and use began to run in new ways

Joint procurement: stable supply of stents

On September 6, the National Organization for the Joint Procurement Office of High-Value Medical Consumables (hereinafter referred to as the Joint Procurement Office) disclosed the main status of the implementation of the results of the centralized procurement of coronary stents since January 2021

The United Procurement Office stated that since the implementation of the results of the centralized procurement of coronary stents organized by the state, the overall progress has been stable, the price has dropped significantly, the supply of selected products is sufficient, and the people have clearly benefited

On the whole, the selected enterprises carefully organize production and supply according to the demand of medical institutions, and the overall supply of various types of stents exceeds the procurement demand

In terms of data, the use of medical institutions is faster than expected

From January to August 2021, the selected companies have supplied 1.

From a national perspective, brackets of various specifications are in stock

The selected company gains 80% market share

Centralized procurement of coronary stents is the first order organized by the state for centralized procurement of high-value medical consumables, and the reform has achieved remarkable results

In terms of doctors, doctors’ income has increased

At the same time, the industrial development environment has been optimized

Still running

The United Procurement Office stated that some new developments in the reform process are worthy of attention

Centralized procurement with a large amount has changed the original circulation model.

First, the changes in the centralized procurement model between the production, distribution and users are still in the process of running-in

The second is the rapid increase in the use of high-priced drug balloons in some hospitals

With regard to the supply of the selected stents, the Joint Procurement Office has been working with relevant departments, enterprises and medical institutions to solve the problem, and has achieved significant improvements

First, further strengthen the production and distribution capabilities of selected products
.
The Joint Procurement Office will closely monitor the procurement, distribution and use of the selected products with provincial procurement agencies, and require the selected companies to strictly perform their contracts, adjust their production capacity to meet demand, and consolidate the selected companies' supply and distribution responsibilities
.

Promote medical institutions to improve the degree of refinement of internal management, and coordinate with relevant departments to guide medical institutions to strengthen procurement and inventory management capacity building, and improve the efficiency of information transmission and procurement operations
.

In addition, standardize the use of drug balloons
.
Cooperate with relevant departments to regulate the use of drug balloons, promote local drug balloon collections, strengthen supervision of medical institutions that use drug balloons abnormally, and write inquiries and interviews when necessary
.

Guocai continues to expand

The national procurement of coronary stents has been in use for 10 months, and a new round of national procurement has arrived
.

On August 23, the National Organization for High-Value Medical Consumables Joint Procurement Office issued the "National Organization for Centralized Procurement of Artificial Joints (GH-HD2021-1)", which consists of a procurement alliance composed of provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps.
Appoint representatives to form a joint procurement office for high-value medical consumables of the national organization, and carry out centralized procurement of high-value medical consumables on behalf of public medical institutions (including military medical institutions) and voluntary medical insurance designated social medical institutions in various regions.
The purchasing center undertakes daily work and implements it in detail
.

The quantity purchased products are: the first replacement artificial total hip joint (hereinafter referred to as the hip joint), and the first replacement artificial total knee joint (hereinafter referred to as the knee joint)
.

On August 26, the State Organization of the Joint Procurement Office of High-Value Medical Consumables held a corporate training conference in Tianjin.
The standard for participation was medical device registrants who have obtained the legal qualifications for initial replacement of artificial total hip joints and initial replacement of artificial total knee joint products ( Agents), and are willing to participate in this centralized procurement of declaration companies, each company can choose 6 personnel to participate
.

Announcement of the highest effective declaration price for each product system category:

Gao Xue pointed out: The declared price is based on the online price after the bidding from multiple provinces.
After collecting all the data, the price is averaged to obtain a figure close to the above price
.
The purpose of determining the highest effective declaration price is to allow all companies to have the opportunity to participate and obtain a final result through healthy competition, instead of letting companies fight for a bottomless low price, and ultimately ensure that the price is relatively reasonable.
Let the company make profits and related services can keep up
.

Zhang Xiangying (a pseudonym), the marketing manager of a well-known medical device company in the industry, said to Cyberlan Devices on the spot: "The price is still under discussion, but I probably have a benchmark in my heart.
In fact, it is the cost price + a small amount of profit.
According to the previous decline in coronary stents, This time, we are ready to cut prices by more than 80%.
One of the purposes of the selection is to let the market remember us.
The domestic market is still the highlight, and the foreign market is too uncertain
.
"

Artificial joints are still under intense national procurement, and the country has already signaled a new city
.
Gao Xue said at the end of the training session: The bidding will start at 10 o'clock on September 14 and it is estimated that it will be over before noon.
Everyone can go back to prepare for the spine, and there will be more work later
.

It is obvious where the next anchor point of Guocai is
.
There is a stent in the front, the existing national mining, and a spine at the back, the expansion of the national mining is already fixed
.